FDA Inspection 1241516 — Globo Pharma Inc

Globo Pharma Inc — FEI 3010935758

The FDA completed an inspection of Globo Pharma Inc on June 21, 2024 in Tampa, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2024
Fiscal Year
2024
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Tampa, FL (United States)

Citations

IDCFRDescription
1554321 CFR 111.260(c)Batch record - date, time; maintenance
1583921 CFR 111.70(e)Specifications - identity, purity, strength, composition